Ariella B. Hanker

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, Alberto Servetto et al. · Nature Communications · 2019 · 419 citations · Full text

Medicine, Oncology, Pharmacology +17

A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamics

Etai Sapoznik, Bo-Jui Chang, Jaewon Huh et al. · eLife · 2020 · 206 citations · Full text

Life Sciences, Biophysics, Cell Biology +17

Mutant <i>PIK3CA</i> accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies

Ariella B. Hanker, Adam D. Pfefferle, Justin M. Balko et al. · Proceedings of the National Academy of Sciences · 2013 · 194 citations · Full text

Medicine, Cell Biology, Oncology +16

In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer

Michalina Janiszewska, Lin Liu, Vanessa Almendro et al. · Nature Genetics · 2015 · 166 citations · Full text

Medicine, Genetics, Oncology +17

An Acquired <i>HER2</i>  T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant–Driven Breast Cancer

Ariella B. Hanker, Monica Red Brewer, Jonathan H. Sheehan et al. · Cancer Discovery · 2017 · 105 citations · Full text

Medicine, Oncology, Pharmacology +14